- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03559829
Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke
Regaining upper extremity function is very important for stroke survivors to increase their independence and ability to perform activities of daily living (ADLs). Outpatient stroke rehabilitation currently takes place in a therapy clinic, however access can be limited by financial resources and transportation difficulties.
The Feasibility of Home-Based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke Study seeks to explore the safety, usability, and efficacy of a home based virtual reality biofeedback system to promote distal upper extremity (wrist and hand) recovery after stroke. The purpose of the study is to assess the feasibility of using a home-based virtual reality system to increase the dose of upper extremity rehabilitation in subacute and chronic stroke patients.
Panoramica dello studio
Descrizione dettagliata
In this pilot study, we propose to test a virtual reality home-based intervention as an alternative or supplement to traditional rehabilitation for upper extremity weakness after stroke. We are hoping to discover that the device is easily adopted by patients and increases the dose of rehabilitation, as well as potentially leads to motor recovery.
With the increasing affordability and accessibility of virtual reality (VR) systems, VR has emerged as a new platform for stroke rehabilitation. VR therapy involves using computer-based programs to simulate daily tasks and events. VR has shown promise in both allowing patients to practice activities that directly translate to their ADLs, as well as motivating them by providing a novel and interesting virtual environment.
Relevance Regaining upper extremity function is very important for stroke survivors to increase their independence and ability to perform ADLs. The large majority of outpatient stroke rehabilitation currently takes place in a therapy clinic, however access is often limited by resource allocation, financial hardship, and transportation difficulties. The Smart Glove can provide an inexpensive and convenient means for stroke patients to continue their rehabilitation in the comfort of their own home.
Patient Population Subacute and chronic stroke patients presenting with upper extremity weakness, as identified by Stanford physicians in clinic, will be eligible for participation in this study. Patients will be screened and selected from the population of people with strokes who are seen in the Stanford Neuroscience Clinic. Patients will be allowed to participate in any scheduled outpatient rehabilitation during the study. The doctor and/or research coordinator may introduce the study to potential candidates in-person in the Stanford Neurology Clinic, and the research coordinator may contact potential candidates by phone after the doctor's referral.
Procedures:
Once the participant has given informed consent and enrolled in the study, they will have a total of five visits, with one visit every two weeks.
Visit one will entail the participant and identified caregiver undergoing training on the use of the Smart Glove by the research coordinator and Neofect staff. This involves donning/doffing of the glove as well as instruction as to how to use the software program. The participant will be issued a Smart Glove and a tablet preloaded with the software. Subjects will also undergo baseline functional testing, including manual muscle testing (MMT), Fugl-Meyer assessment (FM), Jebsen-Taylor hand function test (JTT), and Stroke Impact Scale (SIS). This first visit is expected to take 60-90 minutes. The participant will be expected to use the Smart Glove for 60 min per day for at least 5 days per week.
The subsequent three visits will be at two week intervals and will involve the participant bringing the device to the Clinical and Translational Research Unit (CTRU). The research coordinator will upload the data from the device as well as troubleshoot any device-related issues. These visits will last 15-30 minutes each.
The final visit will occur after eight weeks of Smart Glove use. In addition to downloading the data, the research coordinator will also repeat functional testing functional testing, including manual muscle testing (MMT), Fugl-Meyer assessment (FM), Jebsen-Taylor hand function test (JTT), and Stroke Impact Scale (SIS). This visit will last 45-60 minutes.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
California
-
Stanford, California, Stati Uniti, 94305
- Stanford Hospital and Clinics
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- 1) Age 18 and older 2) Diagnosis of stroke at least three months prior to enrollment 3) Unilateral upper extremity functional deficit after stroke 4) Presence of a score of at least 2 points on the medical research council scale for wrist flexion/extension or forearm pronation/supination 5) Able to provide informed consent 6) Caregiver who is willing to be trained in use of the Smart Glove
Exclusion Criteria:
- 1) Predisposing psychological disorders which could impede participation 2) Severe aphasia resulting in communication difficulties 3) Severe pain impeding upper extremity rehabilitation 4) Pre-existing neurological disorder that causes motor deficits (i.e. Parkinson's disease)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Single Arm - Intervention arm
RAPAEL Smart Glove Arm The participant will be issued a Smart Glove and a tablet preloaded with the game software.
The available games provide various kinds of motion tasks such as ADL-related tasks presented in an entertaining manner.
The learning schedule algorithm automatically adjusts to the optimal level of difficulty to balance challenge and motivation.
The participant will be expected to use the Smart Glove at home for 60 min per day for at least 5 days per week.
|
The RAPAEL Smart Glove is a commercially available, non-invasive biofeedback based system for distal upper extremity rehabilitation.
The Smart Glove is very lightweight and allows for easy movement of all distal upper extremity joints.
It is made of an elastomer material that is simple to maintain and clean.
The Bending Sensor is a variable resistor that changes as it is bent.
The sensor is a 9-axis movement and position sensor that consists of 3 acceleration channels, 3 angular rate channels, and 3 magnetic field channels that measure wrist movements.
They are connected to a computer system which can accurately compute the amount of individual finger movements.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Device Use
Lasso di tempo: 8 weeks
|
Number of days during 8 week study-period that patient used the device.
|
8 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Device Use Daily Average Per Use Day
Lasso di tempo: 8 weeks
|
Daily average number of minutes of device-use per days that device was used.
|
8 weeks
|
|
Device Use Daily Average
Lasso di tempo: 8 weeks
|
Daily average number of minutes of device-use during 8-week intervention period.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Overall Score
Lasso di tempo: 8 weeks
|
Time (in seconds) to complete the total Jebsen-Taylor Hand Function Test administered at 8-weeks.
The test consists of 7 subtests.
Each subtest is allotted a maximum time of 90 seconds.
The total score is the sum of the scores of the seven subtests.
The total score has a maximum of 630 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Fine Score
Lasso di tempo: 8 weeks
|
Time (in seconds) to complete the four fine-motor subtests of the Jebsen-Taylor Hand Function Test administered at 8-weeks.
Each of the four subtests is allotted a maximum time of 90 seconds.
The total score is the sum of the scores of the four subtests.
The total score has a maximum of 360 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Jebsen-Taylor Hand Function Test - Gross Score
Lasso di tempo: 8 weeks
|
Time (in seconds) to complete the three gross-motor subtests of the Jebsen-Taylor Hand Function Test administered at 8-weeks.
Each of the three gross-motor subtests is allotted a maximum time of 90 seconds.
The total gross-motor score is the sum of the scores of the three subtests.
The total score has a maximum of 270 seconds and there is no minimum.
Longer time to complete the test indicates worse hand function.
|
8 weeks
|
|
Fugl-Meyer Assessment
Lasso di tempo: 8 weeks
|
Upper Extremity Fugl-Meyer Test score at 8-weeks.
Score ranges from 0 to 66, with higher scores corresponding to better arm function.
|
8 weeks
|
|
Manual Muscle Testing (MMT) Score
Lasso di tempo: 8 weeks
|
The MMT score is the sum of the Medical Research Council (MRC) scores across 5 domains (elbow flexor, elbow extensor, wrist extension, finger extension and finger flexion) at 8 weeks.
Each domain has a scale range of 0 to 5, with higher scores corresponding to better strength.
Maximum MMT score ranges from 0-25, with higher scores corresponding to better strength.
|
8 weeks
|
|
Stroke Impact Scale (SIS)
Lasso di tempo: 8 weeks
|
Score on the SIS at 8-weeks.
The score ranges from 0 to 100, with higher scores corresponding to better recovery from stroke.
|
8 weeks
|
|
Patient Experience
Lasso di tempo: 8 weeks
|
Patient self-reported satisfaction with device use (5-point Likert Scale, with higher scores indicating greater satisfaction).
|
8 weeks
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Kara Flavin, MD, Stanford University
- Investigatore principale: Maarten Lansberg, MD, Stanford University
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 37580
- 125802 (Altro identificatore: Stanford)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .